Global Kidney Stones Therapeutic Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	168 Pages	TechNavio	May, 2024	INF19006919

Best Price Guarantee
Price	from $2,500
Length	168 Pages
Publisher	TechNavio
Published Date	May, 2024
SKU	INF19006919

Global Kidney Stones Therapeutic Market 2024-2028

The kidney stones therapeutic market is forecasted to grow by USD 537.8 mn during 2023-2028, accelerating at a CAGR of 4.96% during the forecast period. The report on the kidney stones therapeutic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of flexible digital ureteroscopes, rising incidence of urolithiasis among the global population, and increasing prevalence of kidney stone disease.

Technavio's kidney stones therapeutic market is segmented as below:

By End-user

Hospitals
Specialty clinics
Ambulatory surgical centers

By Type

Lithotripsy
Ureteroscopy
Percutaneous nephrolithonomy (PCNL)

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in technologies in kidney stones treatment as one of the prime reasons driving the kidney stones therapeutic market growth during the next few years. Also, rising geriatric population and initiatives to increase public awareness, physician education, and clinical training will lead to sizable demand in the market.

The report on the kidney stones therapeutic market covers the following areas:

Kidney stones therapeutic market sizing
Kidney stones therapeutic market forecast
Kidney stones therapeutic market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney stones therapeutic market vendors that include Anvik Biotech, Aristo Pharma GmbH, Bausch Health Companies Inc., Bayer AG, Biomedix Siomond Pharma, Cipla Inc., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson Services Inc., Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Pfizer Inc., Walter Bushnell, Windlas Biotech Pvt. Ltd., and Worth Medicines Pvt. Ltd.. Also, the kidney stones therapeutic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Kidney Stones Therapeutic Market 2018 - 2022; Historic Market Size - Data Table on Global Kidney Stones Therapeutic Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 6.4 Specialty clinics - Market size and forecast 2023-2028; Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million); Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million); Chart on Specialty clinics - Year-over-year growth 2023-2028 (%); Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%); 6.5 Ambulatory surgical centers - Market size and forecast 2023-2028; Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Lithotripsy - Market size and forecast 2023-2028; Chart on Lithotripsy - Market size and forecast 2023-2028 ($ million); Data Table on Lithotripsy - Market size and forecast 2023-2028 ($ million); Chart on Lithotripsy - Year-over-year growth 2023-2028 (%); Data Table on Lithotripsy - Year-over-year growth 2023-2028 (%); 7.4 Ureteroscopy - Market size and forecast 2023-2028; Chart on Ureteroscopy - Market size and forecast 2023-2028 ($ million); Data Table on Ureteroscopy - Market size and forecast 2023-2028 ($ million); Chart on Ureteroscopy - Year-over-year growth 2023-2028 (%); Data Table on Ureteroscopy - Year-over-year growth 2023-2028 (%); 7.5 Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028; Chart on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million); Data Table on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million); Chart on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%); Data Table on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share by geography 2023-2028 (%); Data Table on Market share by geography 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Anvik Biotech; Anvik Biotech - Overview; Anvik Biotech - Product / Service; Anvik Biotech - Key offerings; 12.4 Aristo Pharma GmbH; Aristo Pharma GmbH - Overview; Aristo Pharma GmbH - Product / Service; Aristo Pharma GmbH - Key offerings; 12.5 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; 12.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.7 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; 12.8 Dr Reddys Laboratories Ltd.; Dr Reddys Laboratories Ltd. - Overview; Dr Reddys Laboratories Ltd. - Business segments; Dr Reddys Laboratories Ltd. - Key news; Dr Reddys Laboratories Ltd. - Key offerings; Dr Reddys Laboratories Ltd. - Segment focus; 12.9 Emcure Pharmaceuticals Ltd.; Emcure Pharmaceuticals Ltd. - Overview; Emcure Pharmaceuticals Ltd. - Product / Service; Emcure Pharmaceuticals Ltd. - Key offerings; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Intas Pharmaceuticals Ltd.; Intas Pharmaceuticals Ltd. - Overview; Intas Pharmaceuticals Ltd. - Product / Service; Intas Pharmaceuticals Ltd. - Key offerings; 12.12 Macleods Pharmaceuticals Ltd.; Macleods Pharmaceuticals Ltd. - Overview; Macleods Pharmaceuticals Ltd. - Product / Service; Macleods Pharmaceuticals Ltd. - Key offerings; 12.13 Medinova Diagnostic Services Ltd.; Medinova Diagnostic Services Ltd. - Overview; Medinova Diagnostic Services Ltd. - Product / Service; Medinova Diagnostic Services Ltd. - Key offerings; 12.14 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.15 Walter Bushnell; Walter Bushnell - Overview; Walter Bushnell - Product / Service; Walter Bushnell - Key offerings; 12.16 Windlas Biotech Pvt. Ltd.; Windlas Biotech Pvt. Ltd. - Overview; Windlas Biotech Pvt. Ltd. - Product / Service; Windlas Biotech Pvt. Ltd. - Key offerings; 12.17 Worth Medicines Pvt. Ltd.; Worth Medicines Pvt. Ltd. - Overview; Worth Medicines Pvt. Ltd. - Product / Service; Worth Medicines Pvt. Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Kidney Stones Therapeutic Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Specialty clinics - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Specialty clinics - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Specialty clinics - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Specialty clinics - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Ambulatory surgical centers - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Ambulatory surgical centers - Year-over-year growth 2023-2028 (%); Exhibits48: Market opportunity by End-user ($ million); Exhibits49: Data Table on Market opportunity by End-user ($ million); Exhibits50: Chart on Type - Market share 2023-2028 (%); Exhibits51: Data Table on Type - Market share 2023-2028 (%); Exhibits52: Chart on Comparison by Type; Exhibits53: Data Table on Comparison by Type; Exhibits54: Chart on Lithotripsy - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Lithotripsy - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Lithotripsy - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Lithotripsy - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Ureteroscopy - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Ureteroscopy - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Ureteroscopy - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Ureteroscopy - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on Percutaneous nephrolithonomy (PCNL) - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on Percutaneous nephrolithonomy (PCNL) - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Type ($ million); Exhibits67: Data Table on Market opportunity by Type ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share by geography 2023-2028 (%); Exhibits70: Data Table on Market share by geography 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity by geography ($ million); Exhibits110: Data Tables on Market opportunity by geography ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: Anvik Biotech - Overview; Exhibits118: Anvik Biotech - Product / Service; Exhibits119: Anvik Biotech - Key offerings; Exhibits120: Aristo Pharma GmbH - Overview; Exhibits121: Aristo Pharma GmbH - Product / Service; Exhibits122: Aristo Pharma GmbH - Key offerings; Exhibits123: Bausch Health Companies Inc. - Overview; Exhibits124: Bausch Health Companies Inc. - Business segments; Exhibits125: Bausch Health Companies Inc. - Key news; Exhibits126: Bausch Health Companies Inc. - Key offerings; Exhibits127: Bausch Health Companies Inc. - Segment focus; Exhibits128: Bayer AG - Overview; Exhibits129: Bayer AG - Business segments; Exhibits130: Bayer AG - Key news; Exhibits131: Bayer AG - Key offerings; Exhibits132: Bayer AG - Segment focus; Exhibits133: Cipla Inc. - Overview; Exhibits134: Cipla Inc. - Business segments; Exhibits135: Cipla Inc. - Key news; Exhibits136: Cipla Inc. - Key offerings; Exhibits137: Cipla Inc. - Segment focus; Exhibits138: Dr Reddys Laboratories Ltd. - Overview; Exhibits139: Dr Reddys Laboratories Ltd. - Business segments; Exhibits140: Dr Reddys Laboratories Ltd. - Key news; Exhibits141: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits142: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits143: Emcure Pharmaceuticals Ltd. - Overview; Exhibits144: Emcure Pharmaceuticals Ltd. - Product / Service; Exhibits145: Emcure Pharmaceuticals Ltd. - Key offerings; Exhibits146: GlaxoSmithKline Plc - Overview; Exhibits147: GlaxoSmithKline Plc - Business segments; Exhibits148: GlaxoSmithKline Plc - Key news; Exhibits149: GlaxoSmithKline Plc - Key offerings; Exhibits150: GlaxoSmithKline Plc - Segment focus; Exhibits151: Intas Pharmaceuticals Ltd. - Overview; Exhibits152: Intas Pharmaceuticals Ltd. - Product / Service; Exhibits153: Intas Pharmaceuticals Ltd. - Key offerings; Exhibits154: Macleods Pharmaceuticals Ltd. - Overview; Exhibits155: Macleods Pharmaceuticals Ltd. - Product / Service; Exhibits156: Macleods Pharmaceuticals Ltd. - Key offerings; Exhibits157: Medinova Diagnostic Services Ltd. - Overview; Exhibits158: Medinova Diagnostic Services Ltd. - Product / Service; Exhibits159: Medinova Diagnostic Services Ltd. - Key offerings; Exhibits160: Pfizer Inc. - Overview; Exhibits161: Pfizer Inc. - Product / Service; Exhibits162: Pfizer Inc. - Key news; Exhibits163: Pfizer Inc. - Key offerings; Exhibits164: Walter Bushnell - Overview; Exhibits165: Walter Bushnell - Product / Service; Exhibits166: Walter Bushnell - Key offerings; Exhibits167: Windlas Biotech Pvt. Ltd. - Overview; Exhibits168: Windlas Biotech Pvt. Ltd. - Product / Service; Exhibits169: Windlas Biotech Pvt. Ltd. - Key offerings; Exhibits170: Worth Medicines Pvt. Ltd. - Overview; Exhibits171: Worth Medicines Pvt. Ltd. - Product / Service; Exhibits172: Worth Medicines Pvt. Ltd. - Key offerings; Exhibits173: Inclusions checklist; Exhibits174: Exclusions checklist; Exhibits175: Currency conversion rates for US$; Exhibits176: Research methodology; Exhibits177: Information sources; Exhibits178: Data validation; Exhibits179: Validation techniques employed for market sizing; Exhibits180: Data synthesis; Exhibits181: 360 degree market analysis; Exhibits182: List of abbreviations